William Gillanders
Professor and Vice-Chair, Department of Surgery, Division of General Surgery, Section of Surgical Oncology, WashU Medicine · Alvin J. Siteman Cancer Center
Credentials: · · ·
History
- Present
Department of Surgery · Alvin J. Siteman Cancer Center
1987–1991
Research
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Nature · 2014 · 1,640 citations
Cell Reports · 2013 · 525 citations
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
Nature · 2020 · 506 citations
44 papers
32 papers
29 papers
27 papers
- KM
15 papers · 3 as a resident
- AC
13 papers
- CM
12 papers
12 papers · 2 as a resident
Grants
- 2026–2031
Development of Novel Neoantigen-Based Spherical Nucleic Acid Immunotherapeutics
National Cancer Institute · R01
Contact PI · $562.6K · Washington University
- 1988–2029
Surgical Oncology Basic Science and Translational Research Training Program
National Cancer Institute · T32
Contact PI · $7.6M · Washington University
- 2023–2028
Washington University SPORE in Pancreatic Cancer
National Cancer Institute · P50
Project lead · $741.4K · Washington University
- 2019–2025
Targeting Neoantigens in Triple Negative Breast Cancer
National Cancer Institute · R01
Contact PI · $3.2M · Washington University
Clinical trials
- 2026–2035
Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients
Principal investigator · Not yet recruiting · Phase 1
Washington University School of Medicine
- 2025–2034
Principal investigator · Recruiting · Phase 1
Washington University School of Medicine
- 2022–2025
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery
Principal investigator · Completed · Phase 1
Washington University School of Medicine
- 2021–2026
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)